Consistently, the orthotopic syngeneic model of pancreatic cancer in C57BL/6 mice verified that the combined treatment of WDR3 silencing and TED-347 treatment further inhibited of tumor growth of pancreatic cancer (Supplementary Fig. 3). The gene discussed is WDR3; the disease is familial pancreatic carcinoma.